Logos Global Management LP
Position in DSGN — Design Therapeutics, Inc.
CIK 1792126
San Francisco, CA
Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,748,000
-$2,702,000 QoQ
Shares Held
1,950,000
-22.0% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. DSGN ranks #29 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,000,000 | $194,500,000 | |
| 2 | ERAS |
Erasca, Inc.
|
11,150,000 | $180,407,000 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
3,450,000 | $114,954,000 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
285,000 | $91,824,150 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
2,125,000 | $84,405,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
1,500,000 | $79,080,000 | |
| 7 | ABVX |
Abivax S.A.
|
675,000 | $75,161,250 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
3,000,000 | $62,760,000 |
All Filings in DSGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,748,000 | 1,950,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,450,000 | 2,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-11-14 | $18,425,000 | 2,500,000 | Shares | Sole | 2025-11-18 | |
| 2025-11-07 | $24,494,400 | 3,240,000 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $27,522,150 | 3,655,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,213,402 | 4,217,627 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,280,040 | 4,217,627 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,022,758 | 4,217,627 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,690,833 | 4,217,627 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,858,878 | 5,032,501 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $20,280,979 | 5,032,501 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,336,127 | 5,032,501 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,876,702 | 5,032,501 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,624,256 | 2,797,501 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,141,580 | 2,797,501 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,702,360 | 2,797,501 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,774,216 | 2,797,501 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,165,014 | 2,797,501 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $45,179,641 | 2,797,501 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $59,359,246 | 2,772,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $40,728,039 | 2,772,501 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $54,349,444 | 2,732,501 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $81,701,779 | 2,732,501 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||